LSVT BIG Certification Training

LSVT Global, Inc. pioneered the Lee Silverman Voice Treatments (LSVT LOUD®; and LSVT BIG®).

These are innovative and clinically-proven methods for improving communication and movement in individuals with Parkinson disease with application to other neurological conditions.

LSVT Global trains Physiotherapists and Occupational Therapists on a derivative of the speech treatment (LSVT LOUD) that is directed at improving the movement, mobility and function with activities of daily living in individuals with Parkinson disease.

Course Beetle are delighted to be hosting this LSVT BIG certification training event in the UK.

This 2-day event is taking place in Birmingham UK on 23/24 March 2019 at the beautiful Studio Venue, situated at the heart of the city, with easy access to all major transport links.

With capacity for attendance by up to 80 HCPC Registered Physiotherapists and Occupational Therapists, this evidence-based, Certification Training is an essential pre-requisite for professionals seeking to offer the therapeutic LSVT BIG protocol to patients with Parkinson’s Disease and other neurological conditions.

Part of the event enables up to 20 people with Parkinson’s Disease to participate as delegates learn and practise LSVT BIG therapy techniques.

Do you want to book onto a course, but need to await approval form your employer?

If so why not register your interest with us by clicking here.

View our LSVT BIG Certification Training

Sponsorship and exhibition opportunities
Course Beetle is a highly specialist training provider working with partner organisations to put on high quality, evidence-based training for UK professionals who work in healthcare, social care and education. For this exciting and ground breaking event Course Beetle are offering sponsorship and exhibition opportunities to organisations to partner with us to welcome and host LSVT BIG Certification to the UK. To find out more about how your organisation can be represented to up to 80 highly specialist clinicians and participating individuals with Parkinson’s Disease, click here.